Indoxyl sulfate aggravates podocyte damage through the TGF-β1/Smad/ROS signaling pathway
Kidney and Blood Pressure Research · 2024
DOI: 10.1159/000538858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney and Blood Pressure Research, 2024. Verfasst von Miao Jia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The People's Hospital of Suzhou New District, Suzhou, China. Hauptthemen laut MEDLINE: Indican, Podocytes, Reactive Oxygen Species, Transforming Growth Factor beta1. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Hyperglycaemia induces the production of a large quantity of reactive oxygen species (ROS) and activates the transforming growth factor β1(TGF-β1)/Smad signalling pathway, which is the main initiating factor in the formation of diabetic nephropathy. Indoxyl sulfate (IS) is a protein-binding gut-derived uraemic toxin that localizes to podocytes, induces oxidative stress and inflames podocytes. The involvement of podocyte damage in diabetic nephropathy through the TGF-β1/) signalling pathway is still unclear.
Methods
In this study, we cultured differentiated rat podocytes in vitro and measured the expression levels of nephrin, synaptopodin, CD2AP, SRGAP2a and α-SMA by quantitative real-time PCR (qRT‒PCR) and western blotting after siRNA-mediated TGF-β1 silencing, TGF-β1 overexpression and the presence of the ROS inhibitor acetylcysteine. We detected the expression levels of nephrin, synaptopodin, CD2AP, SRGAP2a, SRGAP2a in the Smad2/3, phosphorylated-Smad2/3 (p-Smad2/3), Smad7, NADPH oxidase 4 (NOX4), and ROS levels under high glucose (HG) and IS conditions.
Results
The results indicated that nephrin, synaptopodin, CD2AP and SRGAP2a expressions were significantly upregulated and α-SMA expression was significantly downregulated in the presence of HG under siRNA-mediated TGF-β1 silencing or after the addition of acetylcysteine. However, in the presence of HG, the expressions of nephrin, synaptopodin, CD2AP and SRGAP2a were significantly downregulated, and the expression of α-SMA was significantly upregulated with the overexpression of TGF-β1. IS supplementation under HG conditions further significantly reduced the expressions of nephrin, synaptopodin, CD2AP and SRGAP2a; altered the expressions of Smad2/3, p-Smad2/3, Smad7 and NOX4; and increased ROS production in podocytes.
Conclusions
This study suggests that IS may modulate the expression of nephrin, synaptopodin, CD2AP and SRGAP2a by regulating the ROS and TGF-β1/Smad signalling pathways, providing new theoretical support for the treatment of diabetic nephropathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, The People's Hospital of Suzhou New District, Suzhou, China.
Zitieren
APA
Jia, M., Lin, L., Xun, K., Li, D., Wu, W., Sun, S., Qiu, H., & Jin, D. (2024). Indoxyl sulfate aggravates podocyte damage through the TGF-β1/Smad/ROS signaling pathway. Kidney and Blood Pressure Research. https://doi.org/10.1159/000538858
Vancouver
Jia M, Lin L, Xun K, Li D, Wu W, Sun S, et al. Indoxyl sulfate aggravates podocyte damage through the TGF-β1/Smad/ROS signaling pathway. Kidney and Blood Pressure Research. 2024. doi:10.1159/000538858
BibTeX
@article{Jia2024,
author = {Jia, Miao and Lin, Lihua and Xun, Kang and Li, Damei and Wu, Weijiang and Sun, Shaobo and Qiu, Hong and Jin, Donghua},
title = {Indoxyl sulfate aggravates podocyte damage through the TGF-β1/Smad/ROS signaling pathway},
journal = {Kidney and Blood Pressure Research},
year = {2024},
doi = {10.1159/000538858}
}
EUVIMED